Across TCGA pan-cancer cohorts, SSBP3P2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SSBP3P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SSBP3P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SSBP3P2 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

BRCA, PRAD, and LUSC are the cancer types where SSBP3P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SSBP3P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.062	.002	4	view →
PRAD	All	All	+0.279	<.001	2	view →
LUSC	All	All	+0.096	.014	2	view →
COAD	All	III,IV	−0.094	.036	2	view →
LIHC	All	All	+0.011	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: SSBP3P2 RNA expression & survival · all SSBP3P2 data types